Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023

Upgrades

Goldman Sachs upgraded the previous rating for iQIYI Inc IQ from Neutral to Buy. iQIYI earned $0.14 in the fourth quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $7.99 and a 52-week-low of $1.65. iQIYI closed at $7.70 at the end of the last trading period.

For Monster Beverage Corp MNST, Redburn Partners upgraded the previous rating of Neutral to Buy. For the fourth quarter, Monster Beverage had an EPS of $0.57, compared to year-ago quarter EPS of $0.60. The stock has a 52-week-high of $105.45 and a 52-week-low of $71.78. At the end of the last trading period, Monster Beverage closed at $102.01.

According to RBC Capital, the prior rating for Equifax Inc EFX was changed from Sector Perform to Outperform. In the fourth quarter, Equifax showed an EPS of $1.52, compared to $1.84 from the year-ago quarter. At the moment, the stock has a 52-week-high of $243.79 and a 52-week-low of $145.98. Equifax closed at $207.52 at the end of the last trading period.

UBS upgraded the previous rating for Emerson Electric Co EMR from Neutral to Buy. Emerson Electric earned $0.78 in the first quarter, compared to $1.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $100.00 and a 52-week-low of $72.41. Emerson Electric closed at $85.54 at the end of the last trading period.

According to Morgan Stanley, the prior rating for Ternium SA TX was changed from Equal-Weight to Overweight. For the fourth quarter, Ternium had an EPS of $0.20, compared to year-ago quarter EPS of $5.08. At the moment, the stock has a 52-week-high of $50.36 and a 52-week-low of $26.01. Ternium closed at $45.00 at the end of the last trading period.

For Meritage Homes Corp MTH, JP Morgan upgraded the previous rating of Neutral to Overweight. For the fourth quarter, Meritage Homes had an EPS of $7.09, compared to year-ago quarter EPS of $6.25. The current stock performance of Meritage Homes shows a 52-week-high of $117.22 and a 52-week-low of $62.51. Moreover, at the end of the last trading period, the closing price was at $109.98.

JP Morgan upgraded the previous rating for Vir Biotechnology Inc VIR from Neutral to Overweight. For the fourth quarter, Vir Biotechnology had an EPS of $0.76, compared to year-ago quarter EPS of $3.92. The stock has a 52-week-high of $31.78 and a 52-week-low of $18.05. At the end of the last trading period, Vir Biotechnology closed at $22.84.

Needham upgraded the previous rating for HashiCorp Inc HCP from Hold to Buy. The stock has a 52-week-high of $60.03 and a 52-week-low of $21.50. At the end of the last trading period, HashiCorp closed at $31.65.

For REV Group Inc REVG, Baird upgraded the previous rating of Neutral to Outperform. REV Group earned $0.28 in the fourth quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.38 and a 52-week-low of $9.50. REV Group closed at $12.05 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

For Embark Technology Inc EMBK, Vertical Research downgraded the previous rating of Buy to Hold. The current stock performance of Embark Technology shows a 52-week-high of $384.00 and a 52-week-low of $2.02. Moreover, at the end of the last trading period, the closing price was at $3.81.

William Blair downgraded the previous rating for Praxis Precision Medicines Inc PRAX from Outperform to Market Perform. For the fourth quarter, Praxis Precision Medicine had an EPS of $0.87, compared to year-ago quarter EPS of $1.30. The stock has a 52-week-high of $13.87 and a 52-week-low of $0.98. At the end of the last trading period, Praxis Precision Medicine closed at $1.00.

Northland Capital Markets downgraded the previous rating for Allied Motion Technologies Inc AMOT from Outperform to Market Perform. Allied Motion earned $0.60 in the third quarter, compared to $0.41 in the year-ago quarter. The stock has a 52-week-high of $44.88 and a 52-week-low of $21.14. At the end of the last trading period, Allied Motion closed at $44.88.

Jefferies downgraded the previous rating for RH RH from Buy to Hold. In the third quarter, RH showed an EPS of $5.67, compared to $7.03 from the year-ago quarter. The stock has a 52-week-high of $412.72 and a 52-week-low of $207.37. At the end of the last trading period, RH closed at $297.21.

According to RBC Capital, the prior rating for Southwest Gas Holdings Inc SWX was changed from Sector Perform to Underweight. For the fourth quarter, Southwest Gas Hldgs had an EPS of $1.16, compared to year-ago quarter EPS of $1.61. The stock has a 52-week-high of $95.62 and a 52-week-low of $57.93. At the end of the last trading period, Southwest Gas Hldgs closed at $60.37.

Wedbush downgraded the previous rating for Allbirds Inc BIRD from Outperform to Neutral. Allbirds earned $0.15 in the third quarter, compared to $0.25 in the year-ago quarter. The current stock performance of Allbirds shows a 52-week-high of $7.37 and a 52-week-low of $2.14. Moreover, at the end of the last trading period, the closing price was at $3.06.

For The Wendy's Co WEN, Northcoast Research downgraded the previous rating of Buy to Neutral. For the fourth quarter, Wendy's had an EPS of $0.22, compared to year-ago quarter EPS of $0.16. At the moment, the stock has a 52-week-high of $23.78 and a 52-week-low of $15.77. Wendy's closed at $21.93 at the end of the last trading period.

According to Wedbush, the prior rating for Silvergate Capital Corp SI was changed from Neutral to Underperform. In the fourth quarter, Silvergate Capital showed an EPS of $0.48, compared to $0.66 from the year-ago quarter. The current stock performance of Silvergate Capital shows a 52-week-high of $162.65 and a 52-week-low of $4.85. Moreover, at the end of the last trading period, the closing price was at $5.77.

Credit Suisse downgraded the previous rating for Healthcare Realty Trust Inc HR from Outperform to Neutral. Healthcare Realty Trust earned $0.42 in the fourth quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $31.77 and a 52-week-low of $18.16. At the end of the last trading period, Healthcare Realty Trust closed at $19.76.

For D.R. Horton Inc DHI, JP Morgan downgraded the previous rating of Overweight to Neutral. For the first quarter, D.R. Horton had an EPS of $2.76, compared to year-ago quarter EPS of $3.17. The stock has a 52-week-high of $104.14 and a 52-week-low of $59.25. At the end of the last trading period, D.R. Horton closed at $92.78.

For KB Home KBH, JP Morgan downgraded the previous rating of Overweight to Underweight. In the fourth quarter, KB Home showed an EPS of $2.47, compared to $1.91 from the year-ago quarter. At the moment, the stock has a 52-week-high of $40.92 and a 52-week-low of $24.78. KB Home closed at $35.76 at the end of the last trading period.

National Bank Of Canada downgraded the previous rating for SES AI Corp SES from Outperform to Sector Perform. The stock has a 52-week-high of $10.18 and a 52-week-low of $2.87. At the end of the last trading period, SES AI closed at $3.14.

See all analyst ratings downgrades.

Initiations

With a Buy rating, Alliance Global Partners initiated coverage on Athersys Inc ATHX. The price target seems to have been set at $5.50 for Athersys. Athersys earned $1.15 in the third quarter, compared to $1.75 in the year-ago quarter. The stock has a 52-week-high of $33.25 and a 52-week-low of $0.50. At the end of the last trading period, Athersys closed at $1.53.

With a Neutral rating, B of A Securities initiated coverage on NEXTracker Inc NXT. The price target seems to have been set at $36.00 for NEXTracker. The stock has a 52-week-high of $34.84 and a 52-week-low of $28.51. At the end of the last trading period, NEXTracker closed at $33.35.

Credit Suisse initiated coverage on NEXTracker Inc NXT with an Outperform rating. The price target for NEXTracker is set to $36.00. At the moment, the stock has a 52-week-high of $34.84 and a 52-week-low of $28.51. NEXTracker closed at $33.35 at the end of the last trading period.

With a Buy rating, Truist Securities initiated coverage on NEXTracker Inc NXT. The price target seems to have been set at $40.00 for NEXTracker. The current stock performance of NEXTracker shows a 52-week-high of $34.84 and a 52-week-low of $28.51. Moreover, at the end of the last trading period, the closing price was at $33.35.

Roth Capital initiated coverage on NEXTracker Inc NXT with a Buy rating. The price target for NEXTracker is set to $45.00. At the moment, the stock has a 52-week-high of $34.84 and a 52-week-low of $28.51. NEXTracker closed at $33.35 at the end of the last trading period.

Scotiabank initiated coverage on NEXTracker Inc NXT with a Sector Outperform rating. The stock has a 52-week-high of $34.84 and a 52-week-low of $28.51. At the end of the last trading period, NEXTracker closed at $33.35.

With a Buy rating, Jefferies initiated coverage on Merck & Co Inc MRK. The price target seems to have been set at $125.00 for Merck & Co. For the fourth quarter, Merck & Co had an EPS of $1.62, compared to year-ago quarter EPS of $1.80. The stock has a 52-week-high of $115.49 and a 52-week-low of $76.02. At the end of the last trading period, Merck & Co closed at $106.88.

With a Buy rating, Mizuho initiated coverage on NEXTracker Inc NXT. The price target seems to have been set at $40.00 for NEXTracker. The current stock performance of NEXTracker shows a 52-week-high of $34.84 and a 52-week-low of $28.51. Moreover, at the end of the last trading period, the closing price was at $33.35.

With a Neutral rating, Citigroup initiated coverage on NEXTracker Inc NXT. The price target seems to have been set at $36.00 for NEXTracker. The current stock performance of NEXTracker shows a 52-week-high of $34.84 and a 52-week-low of $28.51. Moreover, at the end of the last trading period, the closing price was at $33.35.

With a Buy rating, Ascendiant Capital initiated coverage on ShiftPixy Inc PIXY. The price target seems to have been set at $6.00 for ShiftPixy. ShiftPixy earned $13.88 in the first quarter, compared to $24.00 in the year-ago quarter. The current stock performance of ShiftPixy shows a 52-week-high of $87.00 and a 52-week-low of $4.32. Moreover, at the end of the last trading period, the closing price was at $5.08.

JP Morgan initiated coverage on NEXTracker Inc NXT with an Overweight rating. The price target for NEXTracker is set to $42.00. The current stock performance of NEXTracker shows a 52-week-high of $34.84 and a 52-week-low of $28.51. Moreover, at the end of the last trading period, the closing price was at $33.35.

Barclays initiated coverage on NEXTracker Inc NXT with an Overweight rating. The price target for NEXTracker is set to $42.00. The current stock performance of NEXTracker shows a 52-week-high of $34.84 and a 52-week-low of $28.51. Moreover, at the end of the last trading period, the closing price was at $33.35.

Piper Sandler initiated coverage on Chinook Therapeutics Inc KDNY with an Overweight rating. The price target for Chinook Therapeutics is set to $41.00. In the fourth quarter, Chinook Therapeutics showed an EPS of $0.90, compared to $0.14 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.44 and a 52-week-low of $11.81. Chinook Therapeutics closed at $23.73 at the end of the last trading period.

Jefferies initiated coverage on Bristol-Myers Squibb Co BMY with a Hold rating. The price target for Bristol-Myers Squibb is set to $62.00. For the fourth quarter, Bristol-Myers Squibb had an EPS of $1.82, compared to year-ago quarter EPS of $1.83. The current stock performance of Bristol-Myers Squibb shows a 52-week-high of $81.44 and a 52-week-low of $65.95. Moreover, at the end of the last trading period, the closing price was at $69.30.

Jefferies initiated coverage on Eli Lilly and Co LLY with a Hold rating. The price target for Eli Lilly is set to $290.00. In the fourth quarter, Eli Lilly showed an EPS of $2.09, compared to $2.49 from the year-ago quarter. The current stock performance of Eli Lilly shows a 52-week-high of $384.44 and a 52-week-low of $254.38. Moreover, at the end of the last trading period, the closing price was at $318.43.

With a Hold rating, Jefferies initiated coverage on Pfizer Inc PFE. The price target seems to have been set at $43.00 for Pfizer. Pfizer earned $1.14 in the fourth quarter, compared to $1.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $56.32 and a 52-week-low of $39.80. Pfizer closed at $41.15 at the end of the last trading period.

With a Buy rating, Goldman Sachs initiated coverage on Apple Inc AAPL. The price target seems to have been set at $199.00 for Apple. Apple earned $1.88 in the first quarter, compared to $2.10 in the year-ago quarter. The stock has a 52-week-high of $179.61 and a 52-week-low of $124.17. At the end of the last trading period, Apple closed at $151.03.

Keybanc initiated coverage on SolarEdge Technologies Inc SEDG with a Sector Weight rating. In the fourth quarter, SolarEdge Technologies showed an EPS of $2.86, compared to $1.10 from the year-ago quarter. The stock has a 52-week-high of $375.90 and a 52-week-low of $190.15. At the end of the last trading period, SolarEdge Technologies closed at $326.83.

Keybanc initiated coverage on NEXTracker Inc NXT with a Sector Weight rating. The stock has a 52-week-high of $34.84 and a 52-week-low of $28.51. At the end of the last trading period, NEXTracker closed at $33.35.

See all analyst ratings initiations.